1. Home
  2. ASPS vs LUNG Comparison

ASPS vs LUNG Comparison

Compare ASPS & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Altisource Portfolio Solutions S.A.

ASPS

Altisource Portfolio Solutions S.A.

HOLD

Current Price

$7.06

Market Cap

73.9M

ML Signal

HOLD

Logo Pulmonx Corporation

LUNG

Pulmonx Corporation

HOLD

Current Price

$2.23

Market Cap

63.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASPS
LUNG
Founded
1999
1995
Country
Luxembourg
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
73.9M
63.6M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
ASPS
LUNG
Price
$7.06
$2.23
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$6.81
AVG Volume (30 Days)
24.0K
827.0K
Earning Date
10-23-2025
02-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.00
N/A
Revenue
$169,648,000.00
$91,664,000.00
Revenue This Year
$38.29
$9.21
Revenue Next Year
N/A
$5.03
P/E Ratio
$1,046.65
N/A
Revenue Growth
10.68
15.59
52 Week Low
$4.92
$1.31
52 Week High
$15.96
$9.37

Technical Indicators

Market Signals
Indicator
ASPS
LUNG
Relative Strength Index (RSI) 43.35 51.54
Support Level $6.80 $2.18
Resistance Level $7.53 $2.39
Average True Range (ATR) 0.42 0.16
MACD 0.15 -0.04
Stochastic Oscillator 59.13 15.31

Price Performance

Historical Comparison
ASPS
LUNG

About ASPS Altisource Portfolio Solutions S.A.

Altisource Portfolio Solutions SA is an integrated service provider and marketplace for the real estate and mortgage industries. It operates via two reportable segments, namely Servicer and Real Estate, which derive maximum revenue, and Origination. The Servicer and Real Estate segment provides loan servicers and real estate investors with solutions and technologies that span the mortgage and real estate lifecycle. The Origination segment provides originators with solutions and technologies that span the mortgage origination lifecycle. Altisource mainly serves financial institutions, government-sponsored enterprises, and originators in the United States, with the majority of its revenue flowing from field services and mortgage and real estate solutions.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

Share on Social Networks: